COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 626
[176] Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in
the brain and blood-brain barrier: Versatile breakers and makers. J
Cereb Blood Flow Metab. 2016;36(9):1481-1507.
[177] Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The
blood-spinal cord barrier: morphology and clinical implications.
Ann Neurol. 2011;70(2):194-206.
[178] Wang Y, Jin S, Sonobe Y, et al. Interleukin-1´ induces
blood-brain barrier disruption by downregulating Sonic hedgehog
in astrocytes. PLoS One. 2014;9(10).
[179] Lochhead JJ, McCaffrey G, Quigley CE, et al. Oxidative
stress increases blood-brain barrier permeability and induces
alterations in occludin during hypoxia-reoxygenation. J Cereb
Blood Flow Metab. 2010;30(9):1625-1636.
[180] Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O.
Neuroinflammation and psychiatric illness. J Neuroinflammation.
2013;10:43.
[181] Daneman R, Prat A. The blood-brain barrier. Cold Spring
Harb Perspect Biol. 2015;7(1).
[182] Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial
interactions at the blood-brain barrier. Nat Rev Neurosci.
2006;7(1):41-53.
[183] Zhang L, Rzigalinski BA, Ellis EF, Satin LS. Reduction of
voltage-dependent Mg2+ blockade of NMDA current in
mechanically injured neurons. Science. 1996;274(5294):1921-1923.
[184] Cecchelli R, Berezowski V, Lundquist S, et al. Modelling of the
blood-brain barrier in drug discovery and development. Nat Rev
Drug Discov. 2007;6(8):650-661.
[185] Banks WA. From blood-brain barrier to blood-brain interface:
new opportunities for CNS drug delivery. Nat Rev Drug Discov.
2016;15(4):275-292.
626
